Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
42%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
PBPH
57
HOLDINGS
18%
ALSO IN THNR
THNR
18
HOLDINGS
50%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.9% | 12.2% | 12.2% |
|
ABBVIE INC | 7.4% | 5.8% | 5.8% |
|
MERCK & CO. INC. | 5.2% | 5.2% | 5.2% |
 |
ASTRAZENECA PLC | 4.8% | 6.1% | 4.8% |
|
AMGEN INC | 4.4% | 6.3% | 4.4% |
PBPH Overweight Relative to THNR
|
JOHNSON & JOHNSON | 9.3% |
|
ELI LILLY & CO | 4.7% |
 |
NOVARTIS AG | 4.2% |
|
VERTEX PHARMACEUTICALS INC | 2.7% |
 |
NOVO NORDISK A/S-B | 2.5% |
|
BRISTOL-MYERS SQUIBB CO | 2.5% |
 |
SANOFI-AVENTIS | 1.9% |
|
GSK PLC | 1.8% |
|
ABBVIE INC | 1.5% |
|
MODERNA, INC. | 1.5% |
PBPH Underweight Relative to THNR
|
NOVO-NORDISK A/S-SPONS ADR | -8.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.6% |
 |
CHINA PHARMACEUTICAL GROUP | -4.5% |
 |
INNOVENT BIOLOGICS, INC. | -4.3% |
|
REGENERON PHARMACEUTICALS | -4.3% |
|
VIKING THERAPEUTICS, INC. | -4.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.6% |
|
ZEALAND PHARMA A/S | -3.5% |
 |
HANMI PHARM CO LTD | -2.9% |
|
JIANGSU HENGRUI PHARMACEUT-H | -2.4% |